Please login to the form below

Not currently logged in
Email:
Password:

Esteve appoints Albert Esteve as chairman of the board of directors

He succeeds Joan Esteve, who continues as chairman of the general shareholders meeting

Spanish pharmaceutical group Esteve has appointed Albert Esteve as its chairman of the board of directors to replace Joan Esteve, who will continue serving the group as chairman of the general shareholders meeting.

Albert Esteve joined the group as an assistant to general management and was appointed member of the group’s executive committee and has been chief executive officer since 2011.

Additionally, Staffan Schuberg will join as chief executive officer, effective January 2018, following more than 20 years’ experience from pharmaceutical companies such as Lundbeck, where he held the position of executive vice president and chief commercial officer.

Esteve said: “This is a new challenge that I am facing with tremendous enthusiasm.

“Regarding the CEO appointment, we feel fortunate and are much honoured to welcome Staffan Schuberg as the new executive leader of the group.”

3rd November 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....
Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...